Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population
Gastroenterology Report · 11.01.2025 · 13
DOI: 10.1093/gastro/goaf056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Report, online erschienen am 16.06.2025. Verfasst von Wei Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed to replace the term of non-alcoholic fatty liver disease (NAFLD). To investigate the effect of MASLD on liver fibrosis and validate the clinical utility of MASLD criteria, differences in disease severity and clinical outcomes between MASLD and NAFLD were compared in a biopsy-proven pediatric cohort. The retrospective clinical data of 427 children with biopsy-proven steatotic liver between 2010 and 2021 were consecutively collected and categorized into three distinct subgroups of MASLD-only, NAFLD-only, and MASLD–NAFLD according to the diagnostic guidelines. Patients with MASLD-only and MASLD–NAFLD had more features of metabolic disorders, with higher level of triglycerides but lower level of high-density lipoprotein cholesterol than NAFLD-only. The proportion of significant fibrosis was highest in MASLD-only patients (68.0%), followed by those with MASLD–NAFLD and NAFLD-only (43.3% and 19.4%, respectively; P < 0.001). More steatohepatitis was presented in MASLD–NAFLD group than the other two groups (66.1% vs 30.8% vs 22.6%, P < 0.001). Multivariate regression revealed that children with MASLD-only had 5.8-fold greater risk of significant fibrosis than those with NAFLD-only (P = 0.001). After a median follow-up of 83 months, 14 of 427 patients developed clinical outcomes. Kaplan–Meier curves indicated no difference in the cumulative incidence of clinical events between the groups (log-rank, P = 0.073). Children in MASLD group tended to have concomitant with severe liver fibrosis and related metabolic diseases compared to those with NAFLD-only in pediatric cohort. Thus, the redefinition of MASLD may improve the detection of children with severe disease that need early intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
- Medical School of Chinese PLA, Beijing, P. R. China.
- Department of Hepatology, The First Hospital of Jilin University, Changchun, Jilin, P. R. China.
- First Department of Liver Disease Center, Capital Medical University, Beijing, P. R. China.
- Department of Interventional Ultrasound, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
ORCID-Profile: Ping Liang
Förderung
- National Key R&D Program of China
- Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support
- National Natural Science Foundation of China
Zitieren
APA
Li, W., Jiang, L., Li, M., Lin, C., Zhu, L., Zhao, B., Liu, Y., Li, Y., Jiang, Y., Liu, S., Liang, P., Niu, J., & Zhao, J. (2025). Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population. Gastroenterology Report, 13. https://doi.org/10.1093/gastro/goaf056
Vancouver
Li W, Jiang L, Li M, Lin C, Zhu L, Zhao B, et al. Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population. Gastroenterology Report. 2025;13. doi:10.1093/gastro/goaf056
BibTeX
@article{Li2025,
author = {Li, Wei and Jiang, Lina and Li, Meiling and Lin, Chen and Zhu, Li and Zhao, Bokang and Liu, Yisi and Li, Yan and Jiang, Yiyun and Liu, Shuhong and Liang, Ping and Niu, Junqi and Zhao, Jingmin},
title = {Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population},
journal = {Gastroenterology Report},
year = {2025},
volume = {13},
doi = {10.1093/gastro/goaf056}
}
EUVIMED